Global Med Technologies(R), Inc. Prepares for First Sub-Saharan African Software Installation
April 21 2004 - 10:30AM
PR Newswire (US)
Global Med Technologies(R), Inc. Prepares for First Sub-Saharan
African Software Installation Global Med's Software to Manage
Vein-to-Vein(R) Transfusion Cycle DENVER, April 21
/PRNewswire-FirstCall/ -- Global Med Technologies(R), Inc.
(BULLETIN BOARD: GLOB) ("Global Med" or the "Company"), announces
the kickoff, in May 2004, of its first sub-Saharan African
implementation (with receipt of funds) of its Wyndgate Technologies
("Wyndgate") division's SafeTrace(R) donor management system and
SafeTrace Tx(R)* transfusion management system. This marks the
beginning of Global Med's foray into international markets where
there are abundant opportunities to help underdeveloped countries
upgrade their blood supply. (Logo:
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO ) Blood
centers are faced with blood shortages and an environment of
possible contamination of the blood supply with blood-borne
diseases, such as HIV, hepatitis, West Nile Virus, etc. These
factors, especially the spread of HIV, are becoming drivers in the
international market for blood center and transfusion services.
Most blood banks and hospitals in sub-Saharan Africa utilize manual
processes and maintain only manual records with little or no
computer software or automation to help control the testing and
safe release of blood and blood products. Wyndgate's donor and
hospital transfusion information systems, with their comprehensive
safety features, will help to enhance the quality of blood products
distributed throughout sub-Saharan Africa by helping to ensure that
only suitable blood products are released for transfusion.
Potentially, this may help to decrease the transmission rate of
HIV/AIDS through blood transfusions in sub-Saharan Africa, which in
turn may ultimately help to save many lives. Mick Ruxin, M.D.,
Chairman and CEO of Global Med Technologies, Inc., stated, "This is
truly a milestone for Global Med -- something that the management
team always believed would happen and which has the potential to
catapult the Company into many other countries to sell its medical
software management systems." Dr. Ruxin continued, "This six-figure
agreement in two small African cities, in one small African
country, underscores the $100+ million dollar potential for Global
Med in the international arena. Further, this is true testimony to
the quality of our products and the professionalism and competency
of our employees as we move forward into international markets. We
are very excited by this opportunity and are looking to additional
international sales in the not-too-distant future." Wyndgate has
strategic marketing relationships with companies in the blood
services products industry, such as McKesson Information Solutions,
a division of McKesson Corporation, Siemens Medical Solutions
Health Services Corporation, a multi-billion dollar Siemens
Company, Sysmex InfoSystems America, Inc. (SIA), the Healthcare
Solutions Division of Keane, Inc., Misys Healthcare Systems, and GE
Medical Systems. Through these partnerships, Global Med is poised
to take advantage of expanded market opportunities for its blood
services management software. About Global Med Technologies, Inc.
Global Med Technologies, Inc. is an e-Health medical information
technology company providing information management software
products and services to the healthcare industry. Its Wyndgate
Technologies division is a leading supplier of information
management systems to U.S. blood centers and transfusion services.
Current clients of Wyndgate's products and services manage more
than 3 million units of blood, or over 22% of the U.S. blood
supply, each year. Together, the SafeTrace Tx advanced transfusion
management system and the SafeTrace donor management system provide
Vein-to-Vein(R) tracking from donor collection to patient
transfusion. For more information about Global Med's products and
services, call 800-WYNDGATE or visit http://www.globalmedtech.com/,
http://www.peoplemed.com/ and http://www.wyndgate.com/. *Patent
Pending This news release may include statements that constitute
forward-looking statements, usually containing the words "believe,"
"estimate," "project," "expects" or similar expressions. These
statements are made pursuant to the safe harbor provisions of the
Private Securities Litigation Reform Act of 1995. Forward-looking
statements inherently involve risks and uncertainties that could
cause actual results to differ materially from the forward-looking
statements. By making these forward-looking statements, the Company
undertakes no obligation to update these statements for revisions
or changes after the date of this news release. AP Archive:
http://photoarchive.ap.org PRN Photo Desk, photodesk@prnewswire.com
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGODATASOURCE:
Global Med Technologies, Inc. CONTACT: media, Patti Larson, Senior
Director of Marketing Development, +1-916-404-8492, , or investors,
Tom Marcinek, President and COO, +1-916-404-8413, , both of
Wyndgate Technologies, for Global Med Technologies Web site:
http://www.peoplemed.com/ Web site: http://www.wyndgate.com/ Web
site: http://www.globalmedtech.com/
Copyright